Inventor · disambiguated record
Stéphane De Lombaert
Also filed as: DE LOMBAERT STEPHANE · DE LOMBAERT STEPHANE J · DE LOMBAERT STÉPHANE
46 granted patents·19 pending applications·1,215 citations·filing 1991–2022
98Inventor score
Files withNEUROGEN CORP23CIBA GEIGY CORP5KAROS PHARMACEUTICALS INC5ROIVANT SCIENCES GMBH5BARTOLOZZI ALESSANDRA4
Top patents by PatentIndex Score
65 records- 0198US6506762B1Certain alkylene diamine-substituted heterocyclesNEUROGEN CORP·Filed 2000·Granted Jan 14, 2003·227 cites·97 claims
- 0296US10946018B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsROIVANT SCIENCES GMBH·Filed 2020·Granted Mar 16, 2021·6 cites·18 claims
- 0396US9199994B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsKAROS PHARMACEUTICALS INC·Filed 2014·Granted Dec 1, 2015·31 cites·48 claims
- 0496US6566367B2Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidinesPFIZER·Filed 2001·Granted May 20, 2003·124 cites·23 claims
- 0596US5294632APhosphono/biaryl substituted dipetide derivativesCIBA GEIGY CORP·Filed 1992·Granted Mar 15, 1994·175 cites·10 claims
- 0695US5155100APhosphono/biaryl substituted dipeptide derivativesCIBA GEIGY CORP·Filed 1991·Granted Oct 13, 1992·159 cites·21 claims
- 0794US10660893B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsROIVANT SCIENCES GMBH·Filed 2019·Granted May 26, 2020·6 cites·18 claims
- 0894US10045988B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsROIVANT SCIENCES GMBH·Filed 2017·Granted Aug 14, 2018·11 cites·26 claims
- 0994US9750740B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsKAROS PHARMACEUTICALS INC·Filed 2016·Granted Sep 5, 2017·14 cites·26 claims
- 1094US6372743B1Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazinesNEUROGEN CORP·Filed 2000·Granted Apr 16, 2002·87 cites·50 claims
- 1193US9512122B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsKAROS PHARMACEUTICALS INC·Filed 2015·Granted Dec 6, 2016·15 cites·100 claims
- 1293US7074799B2Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2003·Granted Jul 11, 2006·48 cites·59 claims
- 1392US10350208B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsROIVANT SCIENCES GMBH·Filed 2018·Granted Jul 16, 2019·7 cites·36 claims
- 1491US6943199B2Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidinesNEUROGEN CORP·Filed 2003·Granted Sep 13, 2005·36 cites·22 claims
- 1591US5250522APhosphono/biaryl substituted amino acid derivativesCIBA GEIGY CORP·Filed 1992·Granted Oct 5, 1993·52 cites·19 claims
- 1689US11759462B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsALTAVANT SCIENCES GMBH·Filed 2021·Granted Sep 19, 2023·1 cites·24 claims
- 1788US7304059B2Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2006·Granted Dec 4, 2007·10 cites·58 claims
- 1884US7488740B2Substituted quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2004·Granted Feb 10, 2009·17 cites·48 claims
- 1984US5273990APhosphono substituted tetrazole derivativesCIBA GEIGY CORP·Filed 1992·Granted Dec 28, 1993·52 cites·20 claims
- 2083US9073895B2Biarylamide inhibitors of leukotriene productionBERRY ANGELA·Filed 2011·Granted Jul 7, 2015·8 cites·13 claims
- 2183US6423727B1Certain thiol inhibitors of endothelin-converting enzymeNOVARTIS AG·Filed 2000·Granted Jul 23, 2002·12 cites·17 claims
- 2282US8580829B2Oxadiazole inhibitors of leukotriene productionBARTOLOZZI ALESSANDRA·Filed 2011·Granted Nov 12, 2013·8 cites·18 claims
- 2380US6696445B2Certain alkylene diamine-substituted heterocyclesNEUROGEN CORP·Filed 2002·Granted Feb 24, 2004·11 cites·42 claims
- 2479US6476038B1Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazinesNEUROGEN CORP·Filed 2000·Granted Nov 5, 2002·15 cites·31 claims
- 2578US7566712B2Biaryl piperazinyl-pyridine analoguesNEUROGEN CORP·Filed 2004·Granted Jul 28, 2009·11 cites·59 claims
- 2678US6613782B2Certain thiol inhibitors of endothelin-converting enzymeNOVARTIS AG·Filed 2002·Granted Sep 2, 2003·7 cites·2 claims
- 2777US6436932B1Aminoalkyl substituted pyrrolo[3,2-e] pyridine and pyrrolo[2,3-b]pyrimidine derivatives: modulators of CRF1 receptorsNEUROGEN CORP·Filed 2001·Granted Aug 20, 2002·9 cites·18 claims
- 2876US10710948B2Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1″-biphenyl]-2-yl)-2,2,2-trifluoroethanoneROIVANT SCIENCES GMBH·Filed 2019·Granted Jul 14, 2020·0 cites·9 claims
- 2974US8658661B2Oxadiazole inhibitors of leukotriene productionBARTOLOZZI ALESSANDRA·Filed 2011·Granted Feb 25, 2014·3 cites·20 claims
- 3074US8618300B2Indolizine inhibitors of leukotriene productionBOSANAC TODD·Filed 2009·Granted Dec 31, 2013·2 cites·13 claims
- 3172US7329664B2Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analoguesNEUROGEN CORP·Filed 2004·Granted Feb 12, 2008·5 cites·39 claims
- 3272US7179807B25-substituted-2-arylpyrazinesNEUROGEN CORP·Filed 2003·Granted Feb 20, 2007·7 cites·15 claims
- 3370US9150556B2Benzimidazolone chymase inhibitorsABEYWARDANE ASITHA·Filed 2008·Granted Oct 6, 2015·1 cites·2 claims
- 3470US6310063B1Aminoalkyl substituted pyrrolo [3,2-E]pyridine and pyrollo [2,3-b]pyrimidine derivatives: modulators of CRF1 receptorsNEUROGEN CORP·Filed 1999·Granted Oct 30, 2001·24 cites·15 claims
- 3569US7074929B2Certain alkylene diamine-substituted heterocyclesPFIZER·Filed 2003·Granted Jul 11, 2006·3 cites·1 claims
- 3666US8575201B2Oxadiazole inhibitors of leukotriene productionBARTOLOZZI ALESSANDRA·Filed 2011·Granted Nov 5, 2013·1 cites·24 claims
- 3764US11708365B2Processes for preparing TPH1 inhibitorsALTAVANT SCIENCES GMBH·Filed 2021·Granted Jul 25, 2023·0 cites·25 claims
- 3863US2017204041A1Processes for preparing (r)-1-(5-chloro-[1,1`-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1`-biphenyl]-2-yl)-2,2,2-trifluoroethanoneKAROS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3961US2025066349A1Cyclic compounds and their use for the treatment of neurological disordersPROTHENA BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 4061US2025099442A1Compounds for use in treating neurological disordersPROTHENA BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 4161US2025066318A1Heterocyclic compounds as dyrk1a inhibitorsPROTHENA BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 4260US9611201B2Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanoneKAROS PHARMACEUTICALS INC·Filed 2016·Granted Apr 4, 2017·0 cites·11 claims
- 4360US2008015183A1Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2007·Application pending·0 cites
- 4459US2009286767A1Substituted quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2009·Application pending·0 cites
- 4558US11427558B1Indazoles and azaindazoles as LRRK2 inhibitorsESCAPE BIO INC·Filed 2020·Granted Aug 30, 2022·0 cites·18 claims
- 4658US2019263815A1Processes for preparing tph1 inhibitorsALTAVANT SCIENCES GMBH·Filed 2019·Application pending·0 cites
- 4756US2008153857A1Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analoguesNEUROGEN CORP·Filed 2007·Application pending·0 cites
- 4855US2023077268A1Indazoles and azaindazoles as lrrk2 inhibitorsESCAPE BIO INC·Filed 2022·Application pending·0 cites
- 4951US5644055AAntihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ACECIBA GEIGY CORP·Filed 1994·Granted Jul 1, 1997·8 cites·12 claims
- 5050US2007043056A15-Substituted-2-arylpyrazinesNEUROGEN CORP·Filed 2006·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stéphane De Lombaert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →